Intermountain Medical Center is the flagship hospital of Intermountain Healthcare. Located in Murray, Utah on a 100-acre site at the center of the Salt Lake Valley, Intermountain Medical Center serves as a major adult referral center for six surrounding states and more than 75 regional health care institutions.

There are 452 beds in Intermountain Health Care.

During the past decade, Intermountain Health Care conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 17 clinical trials were completed, i.e. on average, 340% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Intermountain Health Care" #1 sponsor was "National Cancer Institute (NCI)" with 17 trials, followed by "University of Utah" with 5 trials sponsored, "Milestone Pharmaceuticals Inc." with 2 trials sponsored, "Cardiovascular Research Foundation, New York" with 1 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Intermountain Health Care" #1 collaborator was "NRG Oncology" with 5 trials as a collaborator, "National Cancer Institute (NCI)" with 4 trials as a collaborator, "Radiation Therapy Oncology Group" with 4 trials as a collaborator, "NCIC Clinical Trials Group" with 3 trials as a collaborator and "Cancer and Leukemia Group B" with 2 trials as a collaborator. Other collaborators include 11 different institutions and companies that were collaborators in the rest 18 trials.

According to Clinical.Site data, the most researched conditions in "Intermountain Health Care" are "Adult Glioblastoma" (3 trials), "Adult Gliosarcoma" (3 trials), "Cervical Adenocarcinoma" (3 trials), "Fallopian Tube Endometrioid Adenocarcinoma" (3 trials) and "Fallopian Tube Mucinous Adenocarcinoma" (3 trials). Many other conditions were trialed in "Intermountain Health Care" in a lesser frequency.

Most popular intervention types in "Intermountain Health Care" are "Drug" (22 trials), "Other" (13 trials), "Biological" (11 trials), "Device" (4 trials) and "Radiation" (4 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (10 trials), "Bevacizumab" (8 trials), "Paclitaxel" (7 trials), "Quality-of-Life Assessment" (7 trials) and "Carboplatin" (6 trials). Other intervention names were less common.

The vast majority of trials in "Intermountain Health Care" are 18 trials for "All" genders and 11 trials for "Female" genders.

Currently, there are NaN active trials in "Intermountain Health Care". undefined are not yet recruiting, 2 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 18 completed trials in Intermountain Health Care, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Intermountain Health Care, 2 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 6 trials that are defined as “Not Applicable".